Log In
Print this Print this

burixafor (TG-0054)

  Manage Alerts
Collapse Summary General Information
Company TaiGen Biopharmaceuticals Holdings Ltd.
DescriptionCXC chemokine receptor 4 (CXCR4; NPY3R) inhibitor
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionCXC chemokine receptor 4 (CXCR4) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today